SNY

Sanofi (SNY)

Last Price$50.6(1.4%)
Market Cap$141.2B
LTM Revenue
$73.4B
YoY Growth
+52.0%
3Y CAGR
+17.9%
5Y CAGR
+11.9%
Stock quality & Intrinsic value
5/10
0.2% overvalued

Sanofi Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$19.6B
$35.5B
$37.0B
$40.0B
$42.4B
$42.9B
$45.2B
$48.8B
$46.2B
$41.6B
$42.5B
$38.7B
$38.4B
$40.9B
$42.1B
$42.1B
$42.7B
$46.3B
$47.8B
$46.6B
See the SNY
full fundamental analysis
View -->
Overvalued or undervalued?
Check the intrinsic value for SNY
Explore -->

Sanofi (SNY) Revenue comparison analysis

Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Sanofi's Revenue?

As of today, Sanofi's last 12-month Revenue is $73.4B, based on the financial report for Jun 30, 2024 (Q2 2024).

2) What is Sanofi's Revenue growth rate?

Over the last year, Sanofi's Revenue growth was 52.0%. The average annual Revenue growth rates for Sanofi have been 19.9% over the past three years, 11.9% over the past five years.

3) Is Sanofi's Revenue growth rate Good?

Over the last year, Sanofi's Revenue growth was 52.0%, which is higher than industry growth of 0.1%. It indicates that Sanofi's Revenue growth is Good.

4) How does Sanofi's Revenue growth rate compare to its peers?

Over the last year, Sanofi's Revenue growth was 52.0%, which is higher than peer median growth of 1.2%. The list of peers includes JNJ, MRK, PFE, ABBV, NVS, AZN, BMY, LLY, AMGN, GILD etc.